Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN

James, 2005, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera., Nature, 434, 1144, 10.1038/nature03546 Baxter, 2005, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders., Lancet, 365, 1054, 10.1016/S0140-6736(05)71142-9 Levin, 2005, The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia., Blood, 106, 3377, 10.1182/blood-2005-05-1898 Kralovics, 2005, A gain-of-function mutation of JAK2 in myeloproliferative disorders., N Engl J Med, 352, 1779, 10.1056/NEJMoa051113 Yan, 2012, Critical requirement for Stat5 in a mouse model of polycythemia vera., Blood, 119, 3539, 10.1182/blood-2011-03-345215 Walz, 2012, Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice., Blood, 119, 3550, 10.1182/blood-2011-12-397554 Chen, 2010, Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling., Cancer Cell, 18, 524, 10.1016/j.ccr.2010.10.013 Duek, 2014, Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs., Blood, 123, 3943, 10.1182/blood-2013-07-514208 Jenkins, 2005, The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis., Blood, 105, 3512, 10.1182/blood-2004-09-3751 Jenkins, 2007, Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis., Blood, 109, 2380, 10.1182/blood-2006-08-040352 Kirito, 2002, A functional role of Stat3 in in vivo megakaryopoiesis., Blood, 99, 3220, 10.1182/blood.V99.9.3220 Ecker, 2009, The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor., Front Biosci (Landmark Ed), 14, 2944, 10.2741/3425 Eiring, Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia [published online ahead of print August 19, 2014]., Leukemia Alonzi, 2001, Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver., Mol Cell Biol, 21, 1621, 10.1128/MCB.21.5.1621-1632.2001 Göthert, 2005, In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis., Blood, 105, 2724, 10.1182/blood-2004-08-3037 Tiedt, 2008, Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice., Blood, 111, 3931, 10.1182/blood-2007-08-107748 Kühn, 1995, Inducible gene targeting in mice., Science, 269, 1427, 10.1126/science.7660125 Siddiquee, 2007, Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity., Proc Natl Acad Sci USA, 104, 7391, 10.1073/pnas.0609757104 Feil, 1996, Ligand-activated site-specific recombination in mice., Proc Natl Acad Sci USA, 93, 10887, 10.1073/pnas.93.20.10887 Lee, 2002, STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation., Immunity, 17, 63, 10.1016/S1074-7613(02)00336-9 Huang, 2007, STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice., J Clin Invest, 117, 3890, 10.1172/JCI33010 Regis, 2008, Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling., Semin Cell Dev Biol, 19, 351, 10.1016/j.semcdb.2008.06.004 Costa-Pereira, 2002, Mutational switch of an IL-6 response to an interferon-gamma-like response., Proc Natl Acad Sci USA, 99, 8043, 10.1073/pnas.122236099 Schiavone, 2011, The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3., FEBS Lett, 585, 2455, 10.1016/j.febslet.2011.06.020 Kubovcakova, 2013, Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model., Blood, 121, 1188, 10.1182/blood-2012-03-415646 Welte, 2003, STAT3 deletion during hematopoiesis causes Crohn’s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity., Proc Natl Acad Sci USA, 100, 1879, 10.1073/pnas.0237137100 Alonzi, 2004, Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis., Cytokine, 26, 45, 10.1016/j.cyto.2003.12.002 Mantel, 2012, Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype., Blood, 120, 2589, 10.1182/blood-2012-01-404004